Benzinga | Jul 20, 2021 07:13AM EDT

AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2

* AnPac Bio-Medical Science Co Ltd (NASDAQ:ANPC) has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of 2020.

* For 2Q, total paid tests and paid cancer tests increased approximately 280% Q/Q and around 270%, respectively.

* The Company expects that the strong test volume growth will continue throughout this year.

* Price Action: ANPC shares are up 9.5% at $4.39 during the premarket session on the last check Tuesday.